The digital health market access challenge in Australia
What we’re seeing We’ve been working with some remarkable Australian digital health companies lately. These are teams with genuinely impressive clinical evidence […]
Category: Insights
Keeping pace with PBAC and MSAC key dates
Staying ahead in the pharma and medtech sectors requires a deep understanding of regulatory and advisory timelines, such as those set by […]
Positioning Australia’s life sciences industry for global success
Australia is a leader in niche life science segments with strong global markets, including plasma therapies, hearing implants, and sleep apnoea devices. […]
Reimbursement process for high cost highly specialised therapies in public hospitals
In today’s rapidly evolving healthcare landscape, navigating the reimbursement pathway for high-cost highly specialised therapies presents a formidable challenge. These treatments, including […]
Finding Australian Real-World Data for Reimbursement Submissions: A Guide
Introduction Navigating the pathway to reimbursement can often feel like an uphill battle, and you’re not alone in this struggle. Market Access […]
Environmental sustainability in Health Technology Assessment (HTA)
It’s a busy time for sustainability in healthcare: This critical topic is gaining traction in health policy, the MedTech industry, hospitals, and […]
Unlocking Consumer Insights in Health Technology Assessment
Ever asked for feedback? The results can often be quite surprising. We might find ourselves pondering questions like, “Why did they focus […]
Harnessing Real World Data and Evidence
What’s the Difference Between Real World Data and Real World Evidence? While often used interchangeably, there is clear distinction between the terms […]
MedTech innovation insights from global patent trends
The latest patent statistics reveal valuable insights into Australia’s performance in medical technology and pharmaceuticals from 2020 to 2022. Australia’s medical technology […]